Pharming Group

$13.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (+0.39%) As of 4:27 PM UTC today

Why Robinhood?

You can buy or sell Pharming Group and other stocks, options, and ETFs commission-free!

About PHAR

Pharming Group N.V. ADS, each representing 10 ordinary shares, also called Pharming Group, is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The company offers RUCONEST which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands. The listed name for PHAR is Pharming Group N.V. ADS, each representing 10 ordinary shares.

CEO
Sijmen de Vries
Employees
—
Headquarters
Leiden, Zuid-Holland
Founded
1988
Market Cap
842.11M
Price-Earnings Ratio
20.73
Dividend Yield
—
Average Volume
8.43K
High Today
$13.26
Low Today
$13.11
Open Price
$13.25
Volume
35.49K
52 Week High
$21.99
52 Week Low
$12.68

PHAR Earnings

Q4 FY20
Estimated
— per share
Actual
Expected Mar 16, Pre-Market

You May Also Like

PTE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure